SCHEMBL31153490

SCHEMBL31153490

CNC(=O)c1nc2c(N(C)c3ccc(Cl)cc3)nn(C3CCOCC3)c2cc1C(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 P04150 1/20 0.34
▸ PDE7A Q13946 3/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CNR1 P21554 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ CNR2 P34972 1/20 0.33
▸ KCNJ6 P48051 1/20 0.33
▸ KCNJ5 P48544 1/20 0.33
▸ KCNJ3 P48549 1/20 0.33
▸ CREBBP Q92793 3/20 0.33
▸ PDE1A P54750 1/20 0.32
▸ PDE1B Q01064 1/20 0.32
▸ PDE1C Q14123 1/20 0.32
▸ PDE9A O76083 4/20 0.32
▸ SSTR4 P31391 1/20 0.32
▸ PDE4D Q08499 1/20 0.31
▸ MAPK13 O15264 1/20 0.31
▸ MAPK12 P53778 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31153553 0.76 CFTR (0.35) NR3C1CNR1KCNJ6KCNJ5KCNJ3
SCHEMBL31153458 0.76 TUBB4A (0.38) NR3C1KCNJ6KCNJ5KCNJ3CREBBP
SCHEMBL31153419 0.73 CREBBP (0.42) NR3C1CREBBPPDE4DIRAK4
SCHEMBL31153425 0.66 PDE4D (0.35) NR3C1CREBBPPDE4DKDM4C
SCHEMBL31153407 0.66 TUBB4A (0.38) NR3C1KCNJ6KCNJ5KCNJ3CREBBP
SCHEMBL22822778 0.65 CREBBP (0.48) CNR1CNR2CREBBPSSTR4IRAK4
SCHEMBL22822410 0.63 CREBBP (0.50) PDE7ACREBBPSSTR4KDM4C
SCHEMBL19657665 0.61 CREBBP (0.48) PDE7ACREBBP
SCHEMBL19657320 0.59 CREBBP (0.52) PDE7ACREBBPKDM4C
SCHEMBL19657312 0.58 CREBBP (0.51) PDE7ACREBBPPDE1APDE1BPDE1C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4698544-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2026-02-25 — — EP disclosed
WO-2024220946-A1 COMPOUNDS AND USES THEREOF FOGHORN THERAPEUTICS INC. (US) 2024-10-24 — — WO disclosed
Send feedback